Novartis has lost a landmark case in the Supreme Court of India in which it sought patent protection for its cancer drug Gleevec.
http://cen.acs.org/articles/91/i14/Novartis-Loses-India-Patent-Fight.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+cen_latestnews+%28Chemical+%26+Engineering+News%3A+Latest+News%29
http://cen.acs.org/articles/91/i14/Novartis-Loses-India-Patent-Fight.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+cen_latestnews+%28Chemical+%26+Engineering+News%3A+Latest+News%29
No comments:
Post a Comment